跳至主要内容
临床试验/CTRI/2022/03/040802
CTRI/2022/03/040802进行中(未招募)2 期

PROphylaxis for paTiEnts at risk of COVID-19 infecTion - PROTECT

The George Institute New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 未提供

排除标准

  • 1) Inability to provide informed consent or to comply with trial procedures
  • 2) COVID-19 at time of enrolment – either positive SARS CoV-2 swab (PCR) or symptoms highly suggestive of COVID-19 infection
  • 3) Known chronic liver disease or hepatic dysfunction as evidenced by ALT or AST > 3x upper limit of the normal range
  • 4) Allergy to niclosamide or history of significant adverse reaction to niclosamide or related compounds, or to any of the excipients used
  • 5) Significant structural nasal disease in the opinion of the investigator
  • 6) Pregnant, trying to conceive, unwilling to use contraception or breastfeeding
  • 7) Participation in another interventional prophylactic or vaccine trial against COVID-19

研究者

发起方
The George Institute New Delhi

相似试验